Trial Profile
A Phase 2, Double-Blind, Randomized, Placebo and Active-Controlled Dose-Finding Study to Assess the Efficacy, Safety and Tolerability of Multiple Oral Doses of ASP1941 in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 01 Jun 2013 Results published in the Journal of Diabetes and its Complications.
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
- 10 May 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.